Regulation is the Moat, Not the Enemy

There’s a familiar lament inside Indian pharma boardrooms and brand team reviews - “Our hands are tied. We can’t say what we want. We can’t do what we want.” Regulation is framed as friction, an external constraint imposed by cautious bureaucracies on otherwise agile, market-driven organizations.That thinking is not just incomplete, it is strategically erroneous. Because in every mature, high-trust industry from financial services to aviation to medtech, regulation is not the enemy of growth. It is the architecture of advantage. Successful companies have not worked around regulation, they built capabilities through it. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit mypharmareviews.substack.com